YOLFTbeta
Galenica Sante AG

Galenica Sante AG

GALE · SW · Healthcare / Medical Distribution

91.20CHF+0.50 (+0.55%)

Price History

Full chart

Market Stats

Previous Close90.70
Open91.40
Day Range90.85 – 91.40
52-Week Range80.30 – 101.54
Volume74.84K
Market Cap4.06B
P/E (TTM)25.23
Forward P/E20.79
EPS3.23
Dividend Yield3.07%
Beta0.28
50-Day Avg83.14
200-Day Avg89.06

About

Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at home; laboratory medicine, pathology and specialized personalized diagnostic services; and develops, markets, and sells healthcare services and products through various distribution channels. The Logistics & IT segment provides various specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers master data systems for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as offers complete management solutions for pharmacies. In addition, it provides on-schedule delivery services to pharmacies, drugstores, doctors, hospitals, and care homes. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Marc Werner
  • Employees6.62K
  • HeadquartersUntermattweg 8, Bern, Switzerland, 3027, Switzerland
  • Websitehttps://www.galenica.com

Leadership

  • Mr. Marc WernerChief Executive Officer · b. 1967
  • Mr. Julian FiessingerChief Financial Officer · b. 1982
  • Ms. Cécile MatterGroup General Counsel · b. 1984
  • Ms. Iris MullerChief Communications Officer · b. 1983
  • Ms. Arianne HaslerChief People & Culture · b. 1979
  • Dr. Jörg KneubühlerAdvisor · b. 1960
  • Dr. Thomas F. SzuranChief of Products & Home Care & Deputy CEO of Galenica Group · b. 1967
  • Mr. Daniele MadonnaChief of Pharmacies Category Management & Health Services · b. 1977
  • Mr. Andreas KochChief of Wholesale & Logistics · b. 1971
  • Ms. Virginie Pache JeschkaChief of Pharmacies Sales · b. 1979

Financials

Income Statement

Currency: CHF2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.83B2.91B3.01B3.15B3.17B3.31B3.48B3.83B4.01B3.75B3.92B4.14B
Growth (%)-+3.14%+3.22%+4.54%+0.82%+4.25%+5.25%+10.20%+4.69%-6.68%+4.67%+5.47%
Cost of Revenue2.15B2.20B2.27B2.83B2.87B2.93B3.13B3.48B3.64B3.36B2.83B3.71B
Gross Profit678.52M717.25M733.96M319.42M303.17M371.87M349.41M350.55M374.13M387.60M1.09B428.80M
Gross Margin24.01%24.61%24.39%10.16%9.56%11.25%10.04%9.14%9.32%10.35%27.73%10.37%
Operating Expense564.77M598.73M610.14M188.70M197.48M208.55M147.16M164.22M181.15M196.31M882.98M206.03M
Operating Income113.75M118.52M123.82M130.72M105.69M163.31M202.25M186.33M192.98M191.28M204.35M222.78M
Operating Margin4.02%4.07%4.12%4.16%3.33%4.94%5.81%4.86%4.81%5.11%5.21%5.39%
EBITDA156.99M161.15M160.05M178.39M147.70M254.69M302.78M300.33M290.46M306.92M331.31M339.18M
EBITDA Margin5.55%5.53%5.32%5.67%4.66%7.70%8.70%7.83%7.24%8.19%8.45%8.20%
Net Income81.82M81.12M83.39M118.80M147.55M124.99M172.25M167.68M165.13M173.60M182.95M181.10M
Net Income Margin2.90%2.78%2.77%3.78%4.65%3.78%4.95%4.37%4.11%4.63%4.67%4.38%
R&D13.98M14.07M12.20M13.51M11.90M13.40M15.70M15.20M13.50M12.70M14.00M8.30M
R&D as % of Total Revenue0.49%0.48%0.41%0.43%0.38%0.41%0.45%0.40%0.34%0.34%0.36%0.20%
Interest Expense18.23M20.29M20.44M2.74M2.80M6.18M5.25M5.66M5.47M15.81M13.15M15.64M
Interest Expense % of Total Revenue0.64%0.70%0.68%0.09%0.09%0.19%0.15%0.15%0.14%0.42%0.34%0.38%

Balance Sheet

Currency: CHF2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.73B1.71B1.73B1.99B1.80B1.86B2.21B2.26B2.62B2.66B2.99B3.07B3.34B
Total Liabilities1.51B1.47B1.47B1.65B936.67M926.49M1.21B1.21B1.38B1.41B1.52B1.52B1.86B
Total Equity209.73M230.30M254.04M329.62M857.28M929.46M993.50M1.05B1.23B1.25B1.47B1.55B1.48B
Cash18.62M22.27M10.50M9.02M96.29M104.97M90.53M59.78M164.98M93.93M116.16M129.68M115.51M
Total Debt917.19M918.29M902.57M1.11B406.29M410.58M656.07M640.63M672.65M686.49M236.04M775.60M1.06B
Net Debt898.57M896.02M892.07M1.10B310.00M305.61M565.54M580.85M507.67M592.56M119.88M645.91M945.46M

Cash Flow

Currency: CHF2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow84.12M132.44M156.82M144.40M173.55M250.44M224.36M333.10M236.87M225.71M264.70M299.76M
Investing Cash Flow-53.62M-55.77M-64.32M-45.49M-87.58M-134.89M-115.65M-88.24M-126.55M-124.17M-151.08M-333.14M
Financing Cash Flow-26.84M-88.42M-93.97M-11.64M-77.28M-129.98M-139.49M-139.63M-181.28M-79.05M-100.22M19.20M
Capital Expenditure41.54M43.85M34.94M28.05M26.96M53.59M55.69M60.07M70.37M76.37M72.36M27.41M
Free Cash Flow42.58M88.58M121.87M116.35M146.59M196.85M168.67M273.02M166.51M149.34M192.34M272.35M
Dividends Paid54.05M46.00M46.00M766.93M81.14M83.92M89.22M89.51M104.81M110.27M110.17M115.11M
FCF to OCF50.62%66.89%77.72%80.58%84.46%78.60%75.18%81.97%70.29%66.16%72.66%90.86%
Dividend Paid to FCF126.93%51.93%37.74%659.14%55.36%42.63%52.89%32.78%62.95%73.84%57.28%42.27%

Earnings

Report DateAug 4, 2016Aug 8, 2017Mar 13, 2018Aug 8, 2018Mar 12, 2019Aug 6, 2019Mar 10, 2020Aug 4, 2020Mar 9, 2021Aug 3, 2021Mar 8, 2022Aug 9, 2022Mar 7, 2023Mar 11, 2025May 22, 2025Aug 7, 2025Oct 23, 2025Dec 31, 2025May 28, 2026Mar 9, 2027
EPS Estimate0.000.000.000.000.000.000.000.000.000.00---0.000.00-0.00-0.00-
EPS Actual0.750.921.271.151.851.311.221.342.141.601.781.671.652.090.001.770.001.860.00-
Surprise--------------------
Timing-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market--Pre-market-Pre-market---After-hours---Pre-market

Key Statistics & Ratios

Market Cap4.06B
Enterprise Value4.29B
Trailing P/E25.23
Forward P/E20.79
PEG Ratio0.00
Price / Sales0.95
Price / Book2.90
EPS3.23
Book Value28.30
Revenue (TTM)4.29B
Gross Profit (TTM)534.00M
EBITDA255.69M
Profit Margin3.72%
Operating Margin3.89%
Return on Equity11.36%
Return on Assets4.00%
Shares Outstanding49.82M
Shares Float49.76M
Beta0.28
Dividend Yield3.07%
Dividend Rate2.50
Payout Ratio67.20%

Dividends

20261×
1.25Apr 23, 2026
20251×
1.15Apr 14, 2025
20241×
1.10Apr 12, 2024
20231×
1.10May 5, 2023
20221×
1.05May 13, 2022
20211×
0.90May 17, 2021
20201×
0.90May 22, 2020
20191×
1.70May 6, 2019
20181×
1.65May 14, 2018
20171×
1.20May 26, 2017